Teva Reaffirms 2027 Financial Targets
(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) reaffirmed 2027 financial targets, including 30% operating profit margin, driven by growth and transformation programs. The company said its medicines franchise is on track to exceed $5 billion by 2030. AUSTEDO sales are expe
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
